{"title":"High frequency of melanoma in <i>cdkn2b<sup>-/-</sup></i> /<i>tp53<sup>-/-</sup> Xenopus tropicalis</i>.","authors":"Rensen Ran, Lanxin Li, Peng Cheng, Hongyi Li, Huanhuan He, Yonglong Chen, Jing Hang, Weizheng Liang","doi":"10.7150/thno.97475","DOIUrl":null,"url":null,"abstract":"<p><p><b>Rationale:</b> Melanoma, the deadliest form of skin cancer characterized by high therapy resistance, has undergone extensive investigation through the utilization of BRAF<sup>V600E</sup>-driven melanoma animal models. However, there exists a paucity of animal models for the rare hereditary melanoma resulting from germline <i>CDKN2A</i> mutations. <b>Methods:</b> Here, employing CRISPR/Cas9 technology, we generated <i>cdkn2b<sup>-/-</sup>/tp53<sup>-/-</sup> Xenopus tropicalis</i> on a <i>tp53</i> knockout background to model human <i>CDKN2A</i> germline mutation-induced hereditary melanoma. <b>Results:</b> The findings unveiled that <i>cdkn2b<sup>-/-</sup>/tp53<sup>-/-</sup></i> frogs spontaneously developed melanoma, pancreatic cancer, and other tumors. Specifically, these frogs exhibited a high penetrance of spontaneous melanoma, sharing characteristics with melanomas in human hereditary melanoma caused by germline <i>CDKN2A</i> mutations. During melanoma development in <i>cdkn2b<sup>-/-</sup>/tp53<sup>-/-</sup></i> frogs, the occurrences of epithelial-to-mesenchymal transition, the reactivation of pigment cell progenitor cell transcriptional states, and the activation in the MAPK, NF-kB, PI3K-Akt, and TGF-β signaling pathways were noted. <b>Conclusions:</b> Overall, <i>cdkn2b<sup>-/-</sup>/tp53<sup>-/-</sup> Xenopus tropicalis</i> provides a vertebrate model for investigating the development of <i>CDKN2A</i> germline mutation-induced hereditary melanoma, contributing to the exploration of the pathogenesis of hereditary melanoma in humans.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"14 19","pages":"7470-7487"},"PeriodicalIF":12.4000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626935/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.97475","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Melanoma, the deadliest form of skin cancer characterized by high therapy resistance, has undergone extensive investigation through the utilization of BRAFV600E-driven melanoma animal models. However, there exists a paucity of animal models for the rare hereditary melanoma resulting from germline CDKN2A mutations. Methods: Here, employing CRISPR/Cas9 technology, we generated cdkn2b-/-/tp53-/- Xenopus tropicalis on a tp53 knockout background to model human CDKN2A germline mutation-induced hereditary melanoma. Results: The findings unveiled that cdkn2b-/-/tp53-/- frogs spontaneously developed melanoma, pancreatic cancer, and other tumors. Specifically, these frogs exhibited a high penetrance of spontaneous melanoma, sharing characteristics with melanomas in human hereditary melanoma caused by germline CDKN2A mutations. During melanoma development in cdkn2b-/-/tp53-/- frogs, the occurrences of epithelial-to-mesenchymal transition, the reactivation of pigment cell progenitor cell transcriptional states, and the activation in the MAPK, NF-kB, PI3K-Akt, and TGF-β signaling pathways were noted. Conclusions: Overall, cdkn2b-/-/tp53-/- Xenopus tropicalis provides a vertebrate model for investigating the development of CDKN2A germline mutation-induced hereditary melanoma, contributing to the exploration of the pathogenesis of hereditary melanoma in humans.
期刊介绍:
Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.